SFM
TENX icon

Sphera Funds Management’s Tenax Therapeutics TENX Stock Holding History

Sphera Funds Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
+127,600
New +$1.63M 0.24% 89

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Sphera Funds Management's TENX Position: Q2 2026 in Review

Sphera Funds Management reduced its Tenax Therapeutics (TENX) stake by 12% in Q2 2026, selling an estimated $202K and leaving 120,200 shares worth $1.75M. The position accounts for 0.23% of the portfolio, ranked #90.

Sphera Funds Management first reported a position in TENX in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.32M in Q4 2025. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Sphera Funds Management held 120,200 shares of Tenax Therapeutics worth $1.75M as of Q2 2026.
  • Sphera Funds Management sold 15,815 Tenax Therapeutics shares in Q2 2026, an estimated $202K.
  • Tenax Therapeutics made up 0.23% of Sphera Funds Management's portfolio in Q2 2026, its #90 holding.
  • Sphera Funds Management first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Sphera Funds Management's Tenax Therapeutics position peaked at $2.32M in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.